Complex biological structures are difficult to create
R&D Focus
Customized 3D bioprinting
Innovative Solution
Brinter’s main product is the a Bioprinter, a multi-material printer that can be scaled up for mass production. The platform is unique in the medical market due to its high modularity and authentic printing capabilities
Solution Effectiveness
Brinter offers a personalized medicine approach using the patient’s cells and the body’s repair mechanisms
Raised via a seed funding round led by early-stage VC firm Innovestor, the capital is set to be used as a means of expanding the company’s operations, allowing it to more easily address the U.S. and European medical markets
Investment Funding
Brinter is looking to acquire additional innovations and companies in the bioimplant space to expand its portfolio, while simultaneously finishing up their fundraising
Awards and Recognitions
Media Apperance
Biopharma Trend, VoxelMatters
M&A and Collabs
Collab
Major distribution partnership signed between Brinter and LEC
Collab
Brinter collaboration with SRM AP University in India
